STOCK TITAN
  1. Home
  2. Sec-filings
  3. TTNP
  4. [EFFECT] TITAN PHARMACEUTICALS INC SEC Filing

[EFFECT] TITAN PHARMACEUTICALS INC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025
Accession Number: 0001829126-25-008005
Submission Type: POS AM
CIK: 0000910267
Company Name: TITAN PHARMACEUTICALS INC
File Number: 333-251187

Source: View Original Filing on SEC EDGAR

Stock TTNP logo
Titan Pharmaceut

NASDAQ:TTNP

TTNP Rankings

#6553 Ranked by Market Cap
N/A Ranked by Dividends

TTNP Latest News

Jun 27, 2025
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Jun 3, 2025
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
Apr 11, 2025
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
Nov 27, 2024
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
Aug 19, 2024
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

TTNP Latest SEC Filings

Oct 9, 2025
[S-8 POS] TITAN PHARMACEUTICALS INC SEC Filing
Oct 9, 2025
[S-8 POS] TITAN PHARMACEUTICALS INC SEC Filing
Oct 9, 2025
[S-8 POS] TITAN PHARMACEUTICALS INC SEC Filing
Oct 8, 2025
[Form 4] TITAN PHARMACEUTICALS INC Insider Trading Activity
Oct 2, 2025
[25-NSE] TITAN PHARMACEUTICALS INC SEC Filing

TTNP Stock Data

6.13M
669.39k
49.68%
2.83%
4.41%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN FRANCISCO